09880.HK · Hong Kong
09880.HK UBTECH: humanoid ramp, still unprofitable
UBTECH (09880.HK) 2025 revenue ¥2.001B (+53.3%), gross margin 37.7% (+9ppt), net loss ~¥0.790B (narrowed from ¥1.160B). Full-size embodied humanoid revenue ~¥0.821B (+2204%), 1,079 units—now the largest segment. HK ~HK$81.6 / mkt ~HK$38.5B. Thesis is embodied-AI delivery, not near-term profits.
Cite a section with a deep link, e.g. /en/r/ubtech-09880-research#thesis
Market snapshot
- HK (~7/31)
- HKD 81.6
- Market cap (approx)
- HKD 38.5B
- 2025 revenue
- CNY 2.0B
- 2025 net loss
- CNY -790.0M
Thesis
UBTECH (09880.HK) is a flagship HK humanoid name. 2025 revenue ¥2.001B (+53.3%); full-size embodied humanoids ~¥0.821B became the largest segment; GM 37.7%; net loss narrowed to ~¥0.790B—still unprofitable.
HK ~HK$81.6 / mkt ~HK$38.5B. Price discovers embodied-AI commercialization slope.
Business
Model: Design/sell service, education, and industrial robots; growth now led by full-size embodied humanoids. Still pre-scale and loss-making; revenue is project/hardware delivery led.
Flagships: Full-size humanoids (~¥0.821B / 1,079 units in 2025); legacy education/industry robots; solutions/services.
Competitiveness: Scarce HK humanoid listing and demo visibility; GM ~37.7% shows mix/pricing progress.
Strategy (12–24m): Industrial/auto scene scale, cost-down and opex leverage; path is orders→delivery→narrower losses—not PE.
Value chain
Position: downstream OEM/solutions integrator — upstream servos/reducers/sensors/compute; downstream industrial/commercial customers.
Supply-chain risks: Critical component cost/supply; yield and delivery cadence delaying recognition.
Price & valuation
In a loss-making phase, frame via orders, mix, and path to breakeven—not PE. Theme premium means fast drawdowns on execution misses.
Financial trend (~24 months)
~8Q revenue and GM in HKD with YoY/QoQ (RMB disclosures FX-converted per meta). Humanoid ramp steps revenue up; project delivery drives QoQ noise.
Revenue · last 8 quarters
Interactive chart available in the reader.
Gross margin · last 8 quarters
Interactive chart available in the reader.
Operations
Key financials
| Item | Value | YoY | Note |
|---|---|---|---|
| Revenue 2025 | ¥2.001B | +53.3% | Mix-shift year |
| Humanoid revenue | ~¥0.821B | +2204% | #1 segment; 1,079 units |
| Gross margin | 37.7% | +9ppt | Mix-led |
| Net loss | ~¥0.790B | narrowed | 2024: −¥1.160B |
| CapEx | ~¥0.614B | +53.2% | Capacity build |
Competition
Peers: global humanoid narratives, domestic startups, and traditional industrial-robot OEMs.
Strengths: HK listing/brand; humanoid revenue already material.
Weaknesses: Ongoing losses/funding needs; cost/reliability vs auto/tech giants; theme-premium drawdowns.
Peer comparison
| Company | Share / position | Margin | Strength | Weakness |
|---|---|---|---|---|
| 优必选 09880.HK | 港股人形代表 | GM ~38% | 全尺寸人形放量 | 仍亏损、商业化早期 |
| 特斯拉 Optimus（参照） | 全球叙事标杆 | — | 品牌与制造体系 | 非纯机器人上市标的 |
| Fourier 等国内同行 | 人形初创集群 | — | 垂直场景试点 | 规模与融资不确定性 |
| 工业机器人本体厂商 | 传统工控 | 稳态更高 | 成熟客户与现金流 | 人形叙事弱 |
Management
Founder-led; roles per HKEX annual report.
Stability call: Stable people, high execution pressure — watch commercialization and cash runway.
Key management (24m)
| Role | Name | Since | 24m change |
|---|---|---|---|
| 董事长/CEO | 周剑（以年报为准） | 创始以来 | 期间无重大披露变动（以公告为准） |
| CFO | 见年报 | 披露任职 | 期间无重大披露变动（以公告为准） |
| 技术负责人 | 见年报 | 披露任职 | 具身智能产品线扩张期 |
Outlook
2026: industrial/auto scene wins, units/ASP, opex leverage, and cash runway.
Scenarios
| Scenario | Conditions | Implication |
|---|---|---|
| Bull | Faster orders; GM holds; losses shrink | Theme premium supported |
| Base | Revenue up, still loss-making | Volatile theme hold |
| Bear | Delivery miss or price war | Narrative unwind |